Anesth Analg 1994; 79:1102-1106
© 1994 International Anesthesia Research Society
A First-Pass Cost Analysis of Propofol Versus Barbiturates for Children Undergoing Magnetic Resonance Imaging
Zeev N. Kain, MD*, ,
Dorothy J. Gaal, MD*,
Tatiana S. Kain, MD ,
David D. Jaeger, MD*, and
Stephen Rimar, MD*,
*Departments of Anesthesiology, Yale University School of Medicine, and Yale-New Haven Hospital, New Haven, Connecticut
Departments of Pediatrics, Yale University School of Medicine, and Yale-New Haven Hospital, New Haven, Connecticut
Departments of Diagnostic Radiology, Yale University School of Medicine, and Yale-New Haven Hospital, New Haven, Connecticut
Intravenous (IV) propofol was compared with IV thiopental/pentobarbital as a sedative for children undergoing magnetic resonance imaging (MRI) of the brain or spine. Fifty-eight outpatients (aged 11 mo to 6 1/2 yr, ASA grade I and II) were enrolled in the study and randomized to two groups. After IV cannulation, Group I received IV propofol (1–2 mg/kg), followed immediately by a propofol infusion (75–100 µg.kg–1.min–1). Group II received IV thiopental (1–3 mg/kg) followed by a pentobarbital bolus (2–3 mg/kg). Supplemental thiopental doses (1–2 mg/kg) were administrated to maintain adequate sedation. Discharge time and postanesthesia recovery scores were determined by an independent blinded observer. Time of recovery to full consciousness in Group I was significantly less than in Group II (19 ± 7 min vs 35 ± 20; P < 0.005). Time to discharge was also significantly less in Group I (24 ± 6 min vs 40 ± 11; P < 0.05). A preliminary cost analysis was applied to the clinical data obtained and to a theoretical model of a pediatric MRI center. Cost analysis of anesthesia services revealed added drug costs ($1600.76 per year for the propofol group) but significant savings of postanesthesia care unit (PACU) nursing time ($5086.67 per year). Outcomes such as patient morbidity and technical quality of the MRI scans did not differ significantly between the two groups. In conclusion, analysis of the clinical data suggests that propofol may be more suitable than barbiturates for children undergoing outpatient procedures despite its higher price. (Anesth Analg 1994;79:1102–6)
This article has been cited by other articles:

|
 |

|
 |
 
P. G. Dalal, D. Murray, T. Cox, J. McAllister, and R. Snider
Sedation and Anesthesia Protocols Used for Magnetic Resonance Imaging Studies in Infants: Provider and Pharmacologic Considerations
Anesth. Analg.,
October 1, 2006;
103(4):
863 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Godambe, V. Elliot, D. Matheny, and J. Pershad
Comparison of Propofol/Fentanyl Versus Ketamine/Midazolam for Brief Orthopedic Procedural Sedation in a Pediatric Emergency Department
Pediatrics,
July 1, 2003;
112(1):
116 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. I. Lundbom, T. Manner, M. Komu, O. Peltola, K. A. Leino, and O. A. Kirvelä
Barbiturate Anesthesia and Brain Proton Spectroscopy
AJNR Am. J. Neuroradiol.,
September 1, 1999;
20(8):
1543 - 1546.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Lowrie, A. H. Weiss, and C. Lacombe
The Pediatric Sedation Unit: A Mechanism for Pediatric Sedation
Pediatrics,
September 1, 1998;
102(3):
e30 - e30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rockoff, C. Cote, R. Kaplan;, D. Ertem, Y. Acar, E. Ozguven, E. Pehlivanoglu;, C. Bell;, R. I. Parker, R. A. Mahan, et al.
Sedation for Procedures
Pediatrics,
December 1, 1997;
100(6):
1045 - 1045.
[Full Text]
[PDF]
|
 |
|
|